ArticleClinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
An Analysis of Incidence, Related Factors and Prophylactic Treatments of Hospital-Acquired Upper Extremity Deep Vein Thrombosis: A Single-Center 13-Year Retrospective Study.
Article in Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Background incidence rates and observed-to-expected ratios of adverse events of special interest after covid-19 mRNA vaccination during pregnancy in France: a nationwide population-based study.The Lancet regional health. Europe · 2026Article
- Case Report: Upper extremity deep vein thrombosis revealing an occult invasive ductal breast carcinoma.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectivesThis study aimed to evaluate the incidence trend and related factors for hospital-acquired upper extremity deep vein thrombosis (HA-UEDVT) in inpatients of a large medical center in China over 13 years, and to summarize and analyze the complications and preventive treatments of HA-UEDVT.MethodsWe conducted a retrospective analysis on the epidemiological characteristics, related factors, and use of different prophylactic anticoagulation methods in patients with HA-UEDVT at Peking University People's Hospital from January 1, 2009, to December 31, 2021. The data of all patients were obtained through the hospital's medical record system.ResultsOver the 13 years, there has been 239 cases of HA-UEDVT, with a much lower incidence rate compared to HA-LEDVT (0.31 vs 2.28 per 1000 admissions). HA-UEDVT incidence peaked in 2015 and 2016 (both 0.44 per 1000 admissions). The highest HA-UEDVT incidence rates were in the respiratory and gastroenterology departments, with 1.13 and 1.22 per 1000 admissions, respectively. The top three related factors of HA-UEDVT were having a CVC, concurrent of breast cancer, and concurrent of HA-LEDVT, with the β values of 4.81, 4.68, and 3.11, respectively. Thrombosis-related preventive measures were implemented in 30.1% of patients, significantly less frequently than HA-LEDVT (30.1% vs 82.4%,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.